India's Glenmark Pharma to sell 75% stake in life sciences unit to Nirma for $680 mln

Alivus Life Sciences

21/09/2023 14:21

Sept 21 (Reuters) - Indian drugmaker Glenmark
Pharmaceuticals  GLEN.NS  said on Thursday it would sell a 75%
stake in unit, Glenmark Life Sciences  GLEM.NS , to Nirma for
56.52 billion rupees ($679.84 million).

($1 = 83.1373 Indian rupees)

 (Reporting by Ashna Teresa Britto)
 ((AshnaTeresa.Britto@thomsonreuters.com;))